About Orthopedic Biomaterial
Orthopedic biomaterial deals with the physical and chemical properties of the material that is implanted into the human body as constituents of devices. The material implanted is designed to perform specific biological functions by substituting or repairing the damaged tissues such as cartilage, bone, ligaments, and tendons. Bone and joint-related degenerative problems affect millions of people worldwide; this is one of the major causes for half of all chronic diseases in people aged above 50 globally. Diseases and conditions in orthopedic such as osteoporosis, arthritis, tumors, trauma, hip and knee replacement, fractures, neck problems, and soft tissue injuries are the main reasons for using temporary, permanent, or biodegradable devices. Therefore, orthopedic biomaterials play a vital role in the implantation of such devices and provide beneficial objective for physiological requirements with the complex interplay of materials properties.
The Global Orthopedic Biomaterials market to grow at a CAGR of 10.78 percent over the period 2013-2018.
Read more details at: http://www.bigmarketresearch.com/global-orthopedic-biomaterials-2014-2018-market
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Orthopedic Biomaterials market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of the following seven products:
• Bone allografts
• Machined bones
• Demineralized Bone Matrix (DBM)
• Bone Morphogenetic Protein (BMP)
• Stem cell therapy
• Synthetic bone substitute
The Global Orthopedic Biomaterials Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Orthopedic Biomaterials market landscape and its growth prospects in the coming years. The...